Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis

Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis

Even if the incidence of tuberculosis (TB) has been decreasing over the last years, the number of patients with TB is increasing worldwide. The emergence of multidrug-resistant and extensively drug-resistant TB is making control of TB more difficult. Mycobacterium bovis bacillus Calmette–Guérin vacc...

Full description

Bibliographic Details
Main Authors: Marco P. La Manna, Valentina Orlando, Bartolo Tamburini, Giusto D. Badami, Francesco Dieli, Nadia Caccamo
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Immunology
Subjects:
host-directed therapy
tuberculosis
unconventional T cells
cytotoxicity
T cell receptor
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2020.02107/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2020.02107/full

Similar Items